A Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of 14-Day Repeated-Dose Administration of Thiamphenicol (RUX 122) in Healthy Subjects
Sponsor study identifier
interventional
30
1 country
1
Study Start
July 2007
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
September 2007
Actual (reported)Study Completion
April 2008
Actual (reported)The purpose of this study is to determine if two-weeks of dosing with thiamphenicol is safe and is able to change the levels of certain pre-specified biomarkers in nervous tissue taken from the nasal passages.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 2008
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 2007
Date type not reportedThis date has not been verified as actual or estimated.
September 2007
Actual (reported)April 2008
Actual (reported)August 12, 2009
Actual (reported)August 13, 2009
Actual (reported)Amount of EAAT2 RNA in nasal biopsy
Two weeks
Placebo
Active comparator
750 and 1500 mg/day;tablets
SGS Research Unit - Stuivenberg
Antwerp, Belgium
Richard E Chipokin, PhD
Ruxton Pharmaceuticals
30 participants (actual enrollment reported by the registry).
First Submitted
August 12, 2009
First Posted
August 13, 2009
Study Start
July 2007
Date type not reportedThis date has not been verified as actual or estimated.
Contact the study team to confirm eligibility.
Primary Completion
September 2007
Actual (reported)Study Completion
April 2008
Actual (reported)Last Updated
March 25, 2015
Record last verified: 2015-03
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: